Introduction {#s1}
============

In vertebrate genomes, the majority of cytosine residues within CpG dinucleotides are methylated at the 5 position of the cytosine ring (5-methylcytosine, 5mC) ([@bib49]). 5mC is established by the de novo DNA methyltransferases of the Dnmt3 family, and is propagated by the maintenance DNA methyltransferase, Dnmt1 ([@bib24]). In mice, frogs and zebrafish, mutation or morpholino-mediated depletion of *Dnmt1* results in extensive genome-wide methylation loss and embryonic lethality ([@bib3]; [@bib32]; [@bib43]; [@bib47]). In these species, global methylation deficiencies are linked to a variety of adverse outcomes including deregulation of gene expression, derepression of transposons, elevated levels of DNA damage and increased genome instability during mitosis ([@bib46]). Recent studies have further linked global hypomethylation to activation of antiviral signaling pathways in zebrafish mutated for *dnmt1* and in cancer cells treated with the DNA methyltransferase inhibitor 5-azacytidine ([@bib10]; [@bib11]; [@bib44]). While these studies reinforce the general importance of DNA methylation in vertebrate development and tissue homeostasis, the extensive genome-wide loss of methylation in these models makes it difficult to assign significance to methylation deficiencies at any particular subclass of sequence.

The pericentromeric satellite sequences that juxtapose chromosome centromeres represent an essential structural component of chromosomes and a significant source of 5mC in vertebrate genomes. These highly repetitive sequences appear particularly susceptible to methylation loss in cancer and senescent cells, although the consequences of this hypomethylation are not well understood ([@bib19]; [@bib20]; [@bib37]; [@bib38]; [@bib42]; [@bib48]; [@bib56]). In contrast to global hypomethylation, loss of 5mC at pericentromeric repeats is compatible with human development. Individuals with the rare, autosomal recessive disorder Immunodeficiency, Centromere and Facial anomalies (ICF) syndrome show extensive hypomethylation of pericentromeric repeats, while methylation across the rest of the genome is relatively intact ([@bib57]; [@bib60]; [@bib62]). Affected individuals usually die in late childhood or early adulthood, and exhibit variable symptoms including immunoglobulin deficiency, facial dysmorphism, growth retardation and a generalized failure to thrive ([@bib17]). Chromosome anomalies including whole-arm deletions and multiradial chromosomes have also been reported in mitogen-stimulated lymphocytes from ICF-patients. However, similar chromosome anomalies are not observed in primary tissues from affected individuals ([@bib16]).

Homozygosity mapping and whole-exome sequencing have separately implicated four genes in ICF syndrome: DNA Methyltransferase 3B (*DNMT3B,* ICF type-1), Zinc-finger and BTB domain containing 24 (*ZBTB24,* ICF type-2), Cell division cycle associated 7 (*CDCA7,* ICF type-3) and Helicase, lymphoid-specific (*HELLS,* ICF type-4) ([@bib13]; [@bib52]; [@bib65]). Most of the described mutations in *DNMT3B* cause amino acid substitutions within the C-terminal catalytic domain, suggesting they may be hypomorphic. In contrast, the majority of mutations in *ZBTB24*, *CDCA7* and *HELLS* are predicted to cause loss of function. Mechanistically, ZBTB24, CDCA7 and HELLS are thought to converge in a singular pathway that facilitates DNMT3B access to pericentromeric DNA ([@bib29]; [@bib63]).

To date, most studies of pericentromeric 5mC loss have been performed using transformed B-cell lines derived from ICF patients carrying mutations in *DNMT3B* ([@bib17]). Attempts to generate viable mouse models of pericentromeric hypomethylation through mutation of ICF genes have had limited success. Mice harboring ICF-like mutations in *Dnmt3b* exhibit some characteristics of ICF syndrome including small size and facial anomalies. However, most mice die within 24 hr of birth ([@bib58]). Global methylation profiles were not assessed in these mutants; but significant hypomethylation was reported at both pericentromeric repeats and retroviral sequences. Similar perinatal lethality was observed following deletion of the mouse *HELLS* orthologue. In this case, mutations were accompanied by roughly 50% reductions in 5mC, and methylation loss was noted at pericentromeres, retroviruses and some single copy sequences ([@bib51]). Deletion of the mouse *Zbtb24* gene was reported to cause embryonic lethality; but methylation changes in these mutants have not been investigated ([@bib63]).

Here, we describe a viable model of pericentromeric methylation loss, generated through mutation of the zebrafish *zbtb24* gene. Homozygous mutant adults exhibited key phenotypic hallmarks of ICF syndrome including hypomethylation of pericentromeric satellite repeats. Hypomethylation of these repeats was first detected in mutants at 2 weeks post fertilization (wpf) and became more severe as animals matured. This progressive methylation loss allowed us to investigate the primary consequences of pericentromeric hypomethylation in the context of a vertebrate animal. Using this model, we link derepression of transcripts from hypomethylated pericentromeres to activation of an interferon-based innate immune response, and we demonstrate that this response is mediated through the MDA5-MAVS RNA sensing machinery. Our findings provide insights into the earliest consequences of pericentromeric hypomethylation, demonstrating an unappreciated function for methylation of pericentromeric repeats in protecting against autoimmunity.

Results {#s2}
=======

Mutation of zebrafish *zbtb24* causes ICF syndrome-like phenotypes {#s2-1}
------------------------------------------------------------------

The zebrafish genome encodes a single, well-conserved orthologue of ZBTB24, which we mutated using TAL effector nucleases (TALENs) ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"} and [2](#fig1s2){ref-type="fig"}). The recovered 7.9 kb deletion allele (*zbtb24^mk22^*; here after referred to as *zbtb24^Δ^*), eliminates coding sequence between exons 2 and 5 ([Figure 1B](#fig1){ref-type="fig"}). Animals that were homozygous for this deletion lacked detectable *zbtb24* transcripts, suggesting *zbtb24^Δ^* is a null allele ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). *Zbtb24^Δ/Δ^* embryos were born to heterozygous parents at the expected Mendelian ratios and had no obvious morphological abnormalities during the first two weeks of development ([Figure 1C](#fig1){ref-type="fig"}). Phenotypes that were reminiscent of ICF syndrome emerged as animals matured. Consistent with the small stature observed in ICF syndrome, by 3--4 weeks post fertilization (wpf), *zbtb24^Δ/Δ^* mutant zebrafish were smaller than wild-type siblings raised under identical conditions, and this size reduction persisted into adulthood ([Figure 1D--F](#fig1){ref-type="fig"}). As adults, *zbtb24^Δ/Δ^* mutants exhibited facial anomalies that were characterized by a quantifiable elongation of the snout ([Figure 1G--H](#fig1){ref-type="fig"}). We also noted evidence of hypogammagloblulinemia in the presence of normal lymphoid cell numbers, which is an immunological hallmark of ICF syndrome ([Figure 1I--J](#fig1){ref-type="fig"}). Significant death was noted among homozygous mutants at 4 months of age and fewer than 10% of *zbtb24^Δ/Δ^* animals survived beyond 8 months ([Figure 1K](#fig1){ref-type="fig"}). Attempts to recover fertilized embryos by intercrossing or outcrossing *zbtb24^Δ/Δ^* adults were unsuccessful, suggesting that animals were sterile ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). Gonadal morphology in *zbtb24^Δ/Δ^* mutants appeared overtly similar to wild-type siblings in histological sections ([Figure 1---figure supplement 3B--C](#fig1s3){ref-type="fig"}). However, testes size and sperm count were severely reduced in *zbtb24* mutants, providing one potential explanation for impaired male fertility ([Figure 1---figure supplement 3D--G](#fig1s3){ref-type="fig"}). Similar ICF-like phenotypes were observed in zebrafish that were homozygous for a second independently-isolated mutant allele of *zbtb24* (*zbtb24^mk19^*) ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Taken together, these findings identify *zbtb24* homozygous mutant zebrafish as a faithful animal model of ICF syndrome phenotypes.

![Mutation of *zbtb24* causes ICF syndrome-like phenotypes in zebrafish.\
(**A**) Schematic of human and zebrafish Zbtb24 proteins. The BTB/POZ domain is indicated in blue and C2H2-type zinc fingers in dark grey. (**B**) Schematic of zebrafish *zbtb24* gene. Location of TALEN target sequences are indicated in red (not to scale). Brackets indicate the region deleted by the *zbtb24^mk22(Δ)^* allele. (**C**) Representative images of *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish at 2 wpf. Scale bar: 1 mm. (**D**) Standard length measurements for *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish at 1, 2, 3 and 4 wpf (n ≥ 6 for each group). (**E**) Representative images of *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish at 5 months. Scale bar: 5 mm. (**F**) Average weight of *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish at 5 months (n = 5 for each group). (**G**) Representative images of facial abnormalities in *zbtb24^+/+^* and *zbtb24^Δ/Δ^* adults at 6 months. Scale bar: 2 mm. (**H**) Schematic and quantification of facial abnormalities in *zbtb24^Δ/Δ^* zebrafish (n = 5 for each group). (**I**) Abundance of *IgM*, *IgD* and *IgZ* transcripts in *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish at 6 weeks post fertilization (n = 5 for each group). (**J**) Quantification of lymphoid cell populations in total blood isolated from *zbtb24^+/+^* or *zbtb24^Δ/Δ^* kidney marrow from adults, measured by Forward/Side scatter flow cytometry (n = 11 for each group). (**K**) Kaplan-Meier curve indicating survival among groups of *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish (n = 12 for each group). All error bars indicate standard error of the mean (SEM).](elife-39658-fig1){#fig1}

Progressive methylation loss at pericentromeric repeats in *zbtb24* mutants {#s2-2}
---------------------------------------------------------------------------

Pericentromeric satellite type-1 (Sat1) repeats are found on all zebrafish chromosomes and comprise 5--8% of the zebrafish genome ([@bib41]). As expected, we found that Sat1 sequences from wild-type adults were resistant to digestion with the methylation sensitive restriction enzyme HpyCH4IV, indicating that these pericentromeric repeats were heavily methylated. In contrast to wildtype, Sat1 sequences from *zbtb24^Δ/Δ^* and *zbtb24^mk19/mk19^* mutant adults were readily digested with HpyCH4IV, indicating extensive loss of methylation at these repeats ([Figure 2A--B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Comparable Sat1 methylation deficiencies were observed when DNA was isolated from dissected adult brain, skin, muscle and fin, suggesting that these sequences were similarly hypomethylated in most adult somatic tissues ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"} and [Figure 2---figure supplement 3A](#fig2s3){ref-type="fig"}). Methylation levels at Sat1 repeats appeared normal in remaining sperm extracted from *zbtb24^Δ/Δ^* mutant adults, suggesting methylation loss may be restricted to somatic tissues ([Figure 2---figure supplement 1C--D](#fig2s1){ref-type="fig"}).

![Mutation of *zbtb24* causes progressive methylation loss at pericentromeric satellite repeats.\
(**A**) Southern blot of genomic DNA digested with 5mC-sensitive restriction enzyme HpyCH4IV and probed with zebrafish Sat1 sequence. Each lane represents DNA isolated from one adult individual of the indicated genotype. DNA from *dnmt1^-/-^* zebrafish larvae at 7 days post fertilization and their phenotypically wild-type siblings (WT) provides a positive control. (**B**) Quantification of methylation changes at Sat1 sequences in panel **A**). Error bars indicate SEM from the three biological replicates. (**C**) Southern blot of genomic DNA digested with 5mC-sensitive restriction enzyme HpyCH4IV and probed with zebrafish Sat1 sequence. Genomic DNA was isolated from *zbtb24^+/+^* and *zbtb24^Δ/Δ^* animals at 1, 2, 4, 16 and 32 wpf as indicated. (**D**) Quantification of methylation changes at Sat1 sequences in panel **C**). Data represent averages from two independent experiments. Error bars represent the standard deviation (SD). (**E**) Correlation heat map of CpG methylation levels in *zbtb24^+/+^* and *zbtb24^Δ/Δ^* as assessed by ERRBS (Data reflects three biological replicates of each genotype). The density of CpGs increases from blue to dark red. (**F**) Violin Plots indicating overall CpG methylation levels in fins from adult *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish.](elife-39658-fig2){#fig2}

Somewhat unexpectedly, we found that pericentromeric methylation loss in *zbtb24^Δ/Δ^* mutants was progressive. While extensive hypomethylation of Sat1 sequences was detected in adults lacking *zbtb24*, similar hypomethylation was not observed in mutants at 1 wpf ([Figure 2C--D](#fig2){ref-type="fig"}). At 2 wpf, *zbtb24^Δ/Δ^* mutants exhibited roughly 3-fold increases in HpyCH4IV digestion, and sensitivity to digestion became increasingly pronounced in older animals ([Figure 2C--D](#fig2){ref-type="fig"}). By 32 weeks, Sat1 sequences from *zbtb24* mutants exhibited a 23-fold increase in HpyCH4IV digestion compared to wildtype, suggesting a greater than 95% reduction in methylation of these repetitive sequence blocks. Histone H3 lysine nine trimethylation levels were unaffected at Sat1 sequences in *zbtb24^Δ/Δ^* mutant adults ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

*Zbtb24* mutants exhibit modest reductions in 5mc at non-pericentromeric sequences {#s2-3}
----------------------------------------------------------------------------------

To clarify whether other sequences were also hypomethylated in *zbtb24* mutants, we performed Enhanced Reduced Representation Bisulfite Sequencing (ERRBS) using genomic DNA isolated from the fins of three 6-month-old zbtb24*^Δ/Δ^* mutant adults and three wild-type siblings ([@bib22]). At this stage, Sat1 sequences from isolated fins were 20-fold more sensitive to HypCH4IV in *zbtb24* mutants compared to controls, indicating extensive loss of DNA methylation at pericentromeric repeats ([Figure 2---figure supplement 3A--B](#fig2s3){ref-type="fig"}). We then used ERRBS data to interrogate the methylation status of 979,971 non-pericentromeric CpG sites across the genome in the same tissue samples. Our analysis revealed a strong correlation between genome wide 5mC levels in wild-type and zbtb24*^Δ/Δ^* mutant adults (Pearson's correlation value of 0.928), although overall methylation levels appeared reduced by \~10% at all methylated sequence features in mutants ([Figure 2E--F](#fig2){ref-type="fig"} and [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). Reductions consisted primarily of small-magnitude changes in 5mC across the genome, with only 1.3% (13,205) of examined CpG dinucleotides exhibiting methylation differences of greater than 20%. Consistent with these findings, at a threshold of 20% change (p-value\<0.01), only 55 differentially methylated regions (DMRs) were identified between wild-type and *zbtb*24*^Δ/Δ^* adults ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). Methylation levels at endogenous retroviruses and other transposable elements were also examined by methylation sensitive restriction digest. All tested elements were similarly resistant to digestion in *zbtb*24*^Δ/Δ^* mutant adults and wild-type siblings ([Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}). Collectively, these data indicate that pericentromeres are a predominant site of methylation loss in zbtb24*^Δ/Δ^* mutants.

Mutation of *zbtb24* causes activation of innate immune response genes {#s2-4}
----------------------------------------------------------------------

To gain insights into the early consequences of methylation loss in *zbtb24* mutants, we performed transcriptome analysis on RNA isolated from wild-type and *zbtb24^Δ/Δ^* zebrafish at 2 wpf. At this stage, *zbtb24^Δ/Δ^* mutants remain morphologically indistinguishable from wildtype, but show clear hypomethylation of pericentromeric sequences. RNA-seq identified 58 genes that were downregulated by more than 2-fold in *zbtb24^Δ/Δ^* larvae at 2 wpf, while 119 were upregulated by 2-fold or more ([Figure 3A](#fig3){ref-type="fig"}). No gene enrichment signature was observed among downregulated genes. However, roughly 30% of upregulated genes were associated with activation of the innate immune system. In particular, we noted that upregulated transcripts included those associated with interferon stimulated genes (ISGs) and inflammatory cytokines ([Figure 3B](#fig3){ref-type="fig"}). Consistent with these observations, Gene Set Enrichment Analysis (GSEA) identified significant enrichment of genes involved in viral response, a key function of innate immune pathways ([Figure 3C](#fig3){ref-type="fig"}). Upregulation of ISGs was also observed in *zbtb24^Δ/Δ^* and *zbtb24^mk19/mk19^* mutants by qRT-PCR at 3 wpf, whereas the same genes were expressed at wild-type levels at 1 wpf ([Figure 3D--E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). No immune-related genes (and only one gene differentially upregulated in the RNA-Seq) were found within 100 kb of identified DMRs, suggesting that direct loss of methylation at these sequences was unlikely to cause the response ([Figure 2---figure supplement 3D](#fig2s3){ref-type="fig"} and [Supplementary file 4](#supp4){ref-type="supplementary-material"}). Consistent with previous studies, we found that global methylation depletion using the DNA methyltransferase inhibitor 5-azacytidine also resulted in upregulation of immune response genes ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).

![Mutation of *zbtb24* leads to activation of innate immune response genes.\
(**A**) Volcano plot representation of differential gene expression in *zbtb24^+/+^* vs *zbtb24^Δ/Δ^* zebrafish at 2 wpf. Blue and red points mark genes with \>2 fold downregulation or upregulation respectively. (**B**) RNA-seq heatmap showing innate immune genes upregulated in *zbtb24^Δ/Δ^* mutant compared to *zbtb24^+/+^* siblings. Shown are Z-score normalized gene expression values. (**C**) GSEA of a set of genes involved in Response to Virus in zebrafish comparing *zbtb24^+/+^* vs *zbtb24^Δ/Δ^*. NES, normalized enrichment score; FDR, false discovery rate. (**D**) qRT-PCR demonstrating upregulated interferon and inflammatory response genes in *zbtb24^Δ/Δ^* mutants at 3 wpf. Expression levels are reported relative to *β-actin.* Error bars indicate SEM from at least 3 independent biological replicates with n = 8 total animals for each replicate. (**E**) qRT-PCR analysis reveals similar expression of interferon genes in *zbtb24^+/+^* and *zbtb24^Δ/Δ^* larvae at 1 wpf. Error bars represent SEM from at least five biological replicates.](elife-39658-fig3){#fig3}

The innate immune response in *zbtb24* mutants is mediated by sensors of cytosolic RNA {#s2-5}
--------------------------------------------------------------------------------------

The innate immune system represents an ancient defense system in which pathogen-associated molecular patterns (PAMPs) are recognized by pattern recognition receptors (PRRs). These PRRs induce signaling cascades that drive the production of interferons and other inflammatory cytokines with antiviral and immune modulating functions ([@bib45]). In addition to extracellular pathogens, PRRs also recognize PAMPs associated with cell-intrinsic stimuli including DNA damage, endogenous retroviral RNA and RNA-DNA hybrids ([@bib11]; [@bib26]; [@bib35]; [@bib44]).

To clarify the origin of the response in *zbtb24* mutants, we examined the major families of PRRs involved in innate immunity. These include the Toll-like receptors (TLRs), which have broad functions in detecting PAMPs, the RIG-I like receptors (RLRs), which are involved in the detection of cytosolic RNA and cGAMP synthase (cGAS), which functions as a cytosolic sensor of DNA and RNA/DNA hybrids ([@bib12]). Mutations in key mediator proteins required to propagate interferon signaling from each PRR family were introduced onto the *zbtb24* mutant background and we tested the effect on ISG expression. Mutations in the zebrafish orthologs of *mitochondrial antiviral-signaling protein* (*mavs)*, which is an intermediate in RLR signaling and stimulator of interferon genes (sting), which is involved in *cGAS* signaling were generated using CRISPR/Cas9 technology ([Figure 4---figure supplement 1A--B](#fig4s1){ref-type="fig"}). The mutant allele of *Myeloid differentiation primary response 88* (*myd88)*, which is required for signaling through most TLRs, was previously described ([@bib59]).

As in prior experiments, significant increases of the ISGs, *signal transducer and activator of transcription 1b* (*stat1b)* and *interferon regulatory factor* (*irf7)* were observed in *zbtb24^Δ/Δ^* larvae at 3 wpf by qRT-PCR ([Figure 4A--C](#fig4){ref-type="fig"}). Introduction of *myd88* or *sting* mutations had little impact on expression of these ISGs, as similar transcript levels were detected in *zbtb24^Δ/Δ^* single mutant animals compared to *myd88^hu3568/hu3568^; zbtb24^Δ/Δ^* or *sting^mk30/mk30^; zbtb24^Δ/Δ^* double mutants ([Figure 4A--B](#fig4){ref-type="fig"}). Sustained ISG expression in these double mutants suggests limited roles for TLR and cGAS PRRs in mediating the interferon response in *zbtb24* mutants. In contrast to *myd88* and *sting*, mutation of *mavs* suppressed *stat1b* and *irf7* upregulation in *zbtb24^Δ/Δ^* mutant animals. Expression levels of *irf7* and *stat1b* were reduced 2- and 4-fold respectively in *mavs^mk28/mk28^*; z*btb24^Δ/Δ^* double mutants when compared to *zbtb24^Δ/Δ^* single mutant zebrafish, indicating a requirement for *mavs* in the upregulation of these ISGs ([Figure 4C](#fig4){ref-type="fig"}). This finding implicates RLR signaling in the activation of the innate immune system in *zbtb24* mutants and suggests a cytosolic RNA trigger for the response.

![Interferon response in *zbtb24* mutants is mediated by sensors of cytosolic RNA.\
(**A**) Expression of interferon signaling genes *stat1b* and *irf7* in indicated genotypes at 3 wpf. n = 4 biological replicates. (**B**) Expression of the ISGs *stat1b* and *irf7* in indicated genotypes at 3 wpf. n ≥ 7 biological replicates. (**C**) Expression of interferon signaling genes *stat1b* and *irf7* in indicated genotypes at 3 wpf. n ≥ 5 biological replicates. All error bars indicate SEM.](elife-39658-fig4){#fig4}

Pericentromeric RNA transcripts are sufficient to trigger the interferon response in *zbtb24* mutants {#s2-6}
-----------------------------------------------------------------------------------------------------

Given known roles for DNA methylation in transcriptional repression, we next tested whether loss of methylation at pericentromeric sequence resulted in increased levels of Sat1 transcripts that could trigger the RNA mediated interferon response. Consistent with this model, strong derepression of Sat1 RNA from hypomethylated pericentromeres was noted in *zbtb24* mutant adults ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}), whereas transcripts for other dispersed repetitive elements remained unchanged between mutants and wildtype ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Increases in Sat1 transcripts correlated with levels of *irf7* expression in adult zebrafish (r = 0.77), and upregulation of Sat1 transcripts coincided with the window of ISG induction during development ([Figure 5B--C](#fig5){ref-type="fig"}). Both sense and antisense transcripts were detected in mutants using TAG-aided sense/antisense transcript detection (TASA-TD) strand-specific PCR ([@bib27]), suggesting the potential for derepressed Sat1 transcripts to form double stranded RNAs ([Figure 5D--E](#fig5){ref-type="fig"}).

![Pericentromeric transcripts are sufficient to induce the innate immune response in *zbtb24* mutants.\
(**A**) Northern blot analysis of Sat1 transcripts in *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish at 6 wpf. Each lane represents a biological replicate. The lower panel represents the cropped ethidium-bromide stained gel as loading control. (**B**) qRT-PCR for Sat1 transcripts in *zbtb24^+/+^* and *zbtb24^Δ/Δ^* zebrafish at 1, 3 and 6 wpf. Error bars indicate SEM of at least four biological replicates in each group. (**C**) Correlation between the expression of Sat1 and *irf7* in *zbtb24^+/+^* and *zbtb24^Δ/Δ^* at 6 weeks (n = 15). (**D**) TASA-TD PCR amplified sense (s) and antisense (as) transcripts Sat1 (114 bp) and *β-actin* (125 bp) from first strand *zbtb24^Δ/Δ^* cDNA. PCR primers: gene-specific (GS); TAG. The products from TASA-TD PCR were run on the same gel, then cropped and presented. This panel is representative of two independent biological replicates. (**E**) Quantification of TASA-TD from panel **D**). Error bars indicate SD from two biological replicates. (**F**) Expression of interferon stimulated genes in wild-type embryos injected with Sat1 or control RNA encoding a similar-sized fragment of *β*-actin. 50 pg of in vitro transcribed sense and antisense transcripts were injected into wild-type zebrafish embryos at the 1 cell stage. Total RNA was extracted at 8 hr post fertilization for qRT-PCR analysis. Error bars indicate SEM from at least three biological replicates with n = 20 embryos for each biological replicate.](elife-39658-fig5){#fig5}

To determine whether Sat1 transcripts were sufficient to activate an innate immune response, in vitro synthesized RNA corresponding to Sat1 sense and antisense transcripts were injected into wild-type embryos at the 1 cell stage. Expression of the ISGs *stat1b*, *irf7*, *irf1b* and *mxa* was then assessed at 8 hr post fertilization. Co-injection of sense and antisense Sat1 RNA was sufficient to reproducibly cause a 2 to 4-fold upregulation in expression of these ISGs, whereas combined injection of sense and antisense control transcripts encoding a fragment of zebrafish β-actin or GFP had no effect on expression of these genes ([Figure 5F](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Lower level upregulation of some, but not all ISGs was noted when sense or antisense Sat1 transcripts were individually injected into the embryo, suggesting that the response was primarily triggered by formation of Sat1 dsRNA ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Collectively, these results functionally link the derepression of Sat1 transcripts to the activation of the innate immune response in *zbtb24* mutants.

The cytosolic RNA helicase MDA5 is required for the interferon response in *zbtb24* mutants {#s2-7}
-------------------------------------------------------------------------------------------

Finally, we sought to identify the specific PRR required for the interferon response in *zbtb24* mutants. The RLR family of PRRs consists of two RNA helicases that signal through Mavs: Melanoma Differentiation-Associated protein 5 (Mda5) and Retinoic acid-inducible gene I (Rig-I). Rig-I binds 5' triphosphorylated RNA molecules, whereas Mda5 has been implicated in the recognition of long double-stranded RNAs in the cytosol ([@bib12]). Given that 5' triphosphorylation of RNAs is a typical viral signature that is unlikely to be present on endogenous RNA transcripts, we reasoned that Mda5 was a more likely candidate for the receptor. To test the requirement for *mda5*, we generated a seven base-pair deletion in this gene that disrupted the DEAD box helicase domain ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). This *mda5^mk29^* allele was then introduced onto the *zbtb24* mutant background, and expression of the ISGs *stat1b* and *irf7* was examined at 3 wpf and 6 wpf. Homozygous mutation of *mda5* was sufficient to restore *stat1b* and *irf7* expression to wild-type levels in *zbtb24^Δ/Δ^* mutant larvae, suggesting that Mda5 is the primary PPR required for the response ([Figure 6A and B](#fig6){ref-type="fig"}). This requirement was further validated by RNA-seq, which revealed that a broad panel of ISGs that showed elevated expression in *zbtb24* single mutants were no longer upregulated in *mda5*^mk29/mk29^; *zbtb24^Δ/Δ^* double mutants ([Figure 6C](#fig6){ref-type="fig"}).

![Mutation of cytosolic RNA receptor Mda5 mitigates the interferon response in *zbtb24^Δ/Δ^* zebrafish.\
(**A**) Expression of interferon signaling genes *stat1b* and *irf7* in indicated genotypes at 3 wpf. n ≥ 7 biological replicates. (**B**) Expression of interferon signaling genes *stat1b* and *irf7* in indicated genotypes at 6 wpf. n = 6 biological replicates. (**C**) RNA-seq heatmap of interferon stimulated genes upregulated in *zbtb24^Δ/Δ^* zebrafish and rescued in *mda5^mk29/mk29^; zbtb24^Δ/Δ^* zebrafish at 3 wpf. Shown are Z-score normalized gene expression values. (**D**) Model for the activation of interferon response in *zbtb24* mutants. Loss of Zbtb24 function causes hypomethylation of pericentromeric Sat1 repeats, which leads to derepression of associated Sat1 transcripts. These pericentromeric transcripts are recognized by the RNA helicase Mda5 which signals through Mavs and Irf7 to upregulate ISGs. Autoregulatory feedback implicates *irf7* as both an ISG and a key downstream effector of Mda5/Mavs signaling.](elife-39658-fig6){#fig6}

Taken together, these results support a model in which derepression of transcripts from hypomethylated pericentromeres triggers activation of the innate immune system through the Mda5/Mavs viral RNA recognition pathway ([Figure 6D](#fig6){ref-type="fig"}). These findings identify roles for pericentromeric RNA as a trigger of autoimmunity and reveal important functions for pericentromeric methylation in suppressing the generation of these immunostimulatory transcripts. Based on these results, we propose that induction of the innate immune system is one of the earliest in vivo consequences of pericentromeric methylation loss.

Discussion {#s3}
==========

In this study, we describe a viable animal model of ICF syndrome which recapitulates key phenotypic hallmarks of the disease including slow growth, facial anomalies, immunoglobulin deficiencies and reduced lifespan. Given that previous attempts to model ICF syndrome have resulted in perinatal or embryonic lethality ([@bib23]; [@bib58]; [@bib63]), this zebrafish model provides an important new resource for understanding ICF disease etiology during juvenile and adult life stages. In particular, *zbtb24* mutant zebrafish will be useful for understanding phenotypes such as immunoglobulin deficiency, which have not been observed in mouse models and are difficult to study in cell culture systems.

As in ICF syndrome, *zbtb24* mutant adult zebrafish exhibited extensive loss of methylation at pericentromeric sequences. For highly repetitive sequences, methylation sensitive restriction digest followed by Southern blot remains the most effective way to assess methylation levels. By this approach, we observed increases in HpyCH4IV digestion that are consistent with up to 95% reductions in methylation at Sat1 pericentromeric repeats in *zbtb24* mutants. While similar hypomethylation was observed in all adult somatic tissues that we examined, we unexpectedly observed that methylation levels in sperm from *zbtb24* mutants and wildtype animals appeared comparable. This finding raises the possibility that different pathways act to control pericentromeric methylation in germ and somatic cells.

Methylation levels at pericentromeric Sat1 sequences could not be quantified by ERRBS, as this technique relies on MspI restriction digest to enrich for CpG containing sequences, and zebrafish Sat1 repeats are lacking in this restriction site. Nonetheless, ERRBS analysis suggested that the general methylation landscape in human ICF syndrome and in *zbtb24* mutant zebrafish is similar. Methylome analysis of primary blood from ICF patients identified methylation changes of greater than 20% at roughly 3% of examined CpG dinucleotides. Significant changes in methylation of retroviruses and other dispersed repeats were not observed in these patients ([@bib60]). Consistent with these findings, our ERRBS analysis revealed methylation changes of greater than 20% at roughly 1.3% of assayed CpG dinucleotides and found methylation of dispersed repeats to be similar between wildtype and in *zbtb24* mutant zebrafish. The low-level methylation changes outside of the pericentromeres observed in ICF syndrome and our mutants raise the possibility that *zbtb24* may have additional modest roles in maintaining methylation at non pericentromeric sequences. One important caveat of ERRBS analysis is that CpG poor sequences can be under represented, leaving open the possibility that additional DMRs in CpG poor regions of the genome were overlooked by our approach.

The progressive loss of 5mC we observe in somatic tissues between larval and adult stages implicates Zbtb24 in regulating the long-term maintenance of methylation at pericentromeric repeats. We are unaware of any developmental or methylation milestones that can account for the onset of hypomethylation around 2 wpf. Rather, we speculate that the onset of methylation loss at this stage partly reflects the need to deplete maternally loaded *zbtb24* prior to unmasking of the *zbtb24* mutant phenotype and partly reflects the culmination of minor methylation losses due to lower fidelity maintenance over many rounds of cell division. We note that the onset of ICF-like growth defects in *zbtb24* mutant zebrafish emerged in the weeks following Sat1 methylation loss. In at least one case of ICF syndrome type 2, growth reductions and immunodeficiency were also reported to develop with age, raising the possibility that similar progressive methylation loss may impact ICF etiology in humans ([@bib61]). It is also possible that Zbtb24 functions in both maintenance and establishment of pericentromeric methylation, but that requirements for establishment are masked by maternally deposited RNA in *zbtb24* mutant zebrafish lines. Unfortunately, *zbtb24* homozygous mutant zebrafish are sterile, preventing the generation of the maternal-zygotic mutants required to address this question.

Previous studies have suggested that ZBTB24 is a transcription factor that may act to regulate DNA methylation through transcriptional control of the ICF gene CDCA7 ([@bib63]). Consistent with this model, we observe near complete loss of cdca7 expression in *zbtb24* mutants in our RNA-seq data set and by qRT-PCR ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). A more recent study in cultured human cells proposed that ZBTB24 binding might be directly involved in recruiting DNMT3B to promote gene body methylation through recognition of AGGTCCTGGCAG motifs in human cells ([@bib53]). Analysis using Find Individual Motif Occurrences (FIMO) ([@bib25]), did not reveal this motif in the promoter or gene body of zebrafish *cdca7* or at Sat1 sequences.

In the current study, we take advantage of the progressive Sat1 methylation loss in *zbtb24* mutants to identify activation of interferon signaling as one of the earliest in vivo consequences of pericentromeric hypomethylation. This phenotype cannot be attributed to defects in adaptive immunity, as the zebrafish adaptive immune system is not functional until roughly 4 wpf ([@bib55]). Induction of an interferon response has been reported in the context of global hypomethylation in cancer cell lines treated with the DNA methyltransferase inhibitor 5-azacytidine and in zebrafish mutated for the maintenance DNA methyltransferase machinery ([@bib10]; [@bib11]; [@bib44]). In each of these cases induction of the interferon response was attributed to massive derepression of endogenous retroviral elements.

Our results are distinguished from these earlier studies in that we identify hypomethylation of pericentromeric sequences and subsequent derepression of associated satellite transcripts as a previously unappreciated trigger of innate immunity. Immunostimulatory motifs have been noted in pericentromeric RNAs derived from mouse and humans, and transcripts derived from these repeats have been observed in *p53* null mouse fibroblasts following global methylation loss ([@bib33]; [@bib50]). However, while these studies suggest the potential for pericentromeric hypomethylation to drive an interferon response in diverse vertebrate species, experimental evidence in support of this model has been lacking. Here we demonstrate a causative link between derepression of pericentromeric RNAs and the interferon response, and identify a requirement for Mda5/Mavs in mediating the response. Our findings suggest that aberrant Sat1 transcripts derived from pericentromeric repeats trigger this response, and that these transcripts may mimic features of double stranded RNA viruses in the cytosol. This finding raises the possibility that this pathway may also recognize additional endogenous RNAs that lack viral origin.

While mutation of *mda5/mavs* rescued the interferon response in *zbtb24* mutants, *mda5/mavs* mutation had little impact on other ICF phenotypes observed in *zbtb24* mutants. Therefore, we find it unlikely that the interferon response drives ICF etiology. Rather this response represents an additional consequence of pericentromeric hypomethylation. Hypomethylation of pericentromeric sequences is compatible with human viability and is observed in abnormal cell contexts including cancer and senescence. Massive increases in pericentromeric transcripts and upregulation of interferon genes have both been noted in cancer ([@bib9]; [@bib54]). Our data raise the possibility that pericentromeric hypomethylation and subsequent derepression of associated RNAs represents an important but underappreciated trigger of autoimmunity in a variety of disease states.

Materials and methods {#s4}
=====================

Zebrafish husbandry {#s4-1}
-------------------

Zebrafish husbandry and care were conducted in full accordance with animal care and use guidelines with approval by the Institutional Animal Care and Use Committees at Memorial Sloan Kettering Cancer Center and the University of Georgia. Zebrafish were raised under standard conditions at 28° C. Wild-type lines were of the AB background. All mutant alleles are summarized in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

TALEN and CRISPR mutagenesis {#s4-2}
----------------------------

TALEN sequences were selected using Targeter 2.0 software ([@bib15]). TAL repeat assembly was achieved using the Golden Gate assembly method, and assembled repeats were integrated into the GoldyTALEN scaffold ([@bib4]; [@bib8]). Assembled vectors served as templates for in vitro mRNA transcription using the T3 mMessage mMachine kit (Ambion) according to manufacturer's instructions. 50--100 pg mRNA was injected into wild-type embryos at the one-cell stage. Injected embryos were raised to adulthood and F1 progeny were screened for germline transmission of mutations as previously described ([@bib34]). Primers used for detection of mutations and subsequent genotyping are included in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Target selection for CRISPR/Cas9 mediated mutagenesis was performed using CHOPCHOP ([@bib31]). sgRNA templates were generated either by cloning into pT7-gRNA as described by [@bib28] or using the oligo-based approach described in [@bib21] and [@bib7]. All template oligos are listed in [Supplementary file 3](#supp3){ref-type="supplementary-material"}. sgRNAs were in vitro transcribed from their respective templates using T7 RNA polymerase (Promega) as per manufacturer protocol. Cas9 RNA was in vitro transcribed from the pT3TS-nls-zCas9-nls plasmid ([@bib28]) using the T3 mMessage mMachine Kit (Ambion). For mutagenesis, 200--400 ng of sgRNA and \~500 ng of Cas9 mRNA were co-injected into wild-type embryos at the one-cell stage. Injected embryos were raised to adulthood, and F1 progeny were screened for germline transmission of mutations as previously described ([@bib34]). Primers used for detection of mutations and subsequent genotyping are included in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Zebrafish imaging and length measurements {#s4-3}
-----------------------------------------

All bright field imaging of zebrafish larvae and adult was performed using Olympus MVX10 with CellSens Standard software. Standard-length was documented using ImageJ as defined in [@bib39]. Photoshop (Adobe) adjustments to brightness and contrast were equally applied to all images of whole zebrafish in order to improve visualization.

FACS analysis of whole kidney marrow {#s4-4}
------------------------------------

Adult zebrafish at 6 months were sacrificed with a combination of tricaine (Sigma-Aldrich, CAS number 886-86-2) and rapid chilling. Whole kidneys were dissected using forceps and placed in 0.9 × PBS/5% FCS. Manual disaggregation using a P1000 pipette resulted in single cell suspensions. Cells were filtered over a 40 μm nylon mesh filter, and resuspended in PBS/FCS to give a final concentration of 100,000 cells/μl. FACS sorting of single cells were analyzed for forward/side scatter profiles. FACS data were analyzed using FloJo software.

Histology {#s4-5}
---------

For Hematoxylin and Eosin (H and E) staining, adult zebrafish were fixed in 10% Neutral Buffered Formalin for 48 hr. Zebrafish were then decalcified in 0.5 M EDTA for 24 hr. After decalcification, fish were incubated overnight in 70% Ethanol before embedding in paraffin blocks. Sections were stained with H and E according to standard procedures.

Sperm count {#s4-6}
-----------

Adult zebrafish at 8 months were sacrificed with a combination of tricaine and rapid chilling. Whole testis was dissected using forceps and crushed in 100 ul of PBS. For determining sperm-count, sperm samples were diluted 1:20 for each fish. 10 ul of the diluted sample was then loaded onto a hemocytometer (Bright-Line, Hauser Scientific) for counting. The volume over the central counting area is 0.1 mm^3^ or 0.1 microliter. Average number of sperm counted over the central counting area was multiplied by 10000 to obtain the number of sperm/ml of the diluted sample. The obtained value was multiplied by the dilution factor to obtain the final sperm count.

DNA methylation analysis {#s4-7}
------------------------

For Southern blot analysis, 1 μg of purified total genomic DNA was digested with the indicated methylation sensitive restriction enzyme, fractionated by electrophoresis through a 0.9% agarose gel and transferred to nylon membrane. Sperm DNA was isolated from sperm samples collected by crushing dissected testes in PBS. Probes were PCR amplified using primers in [Supplementary file 2](#supp2){ref-type="supplementary-material"} and radiolabeled with ^32^P-dCTP using Rediprime^TM^ II Random Prime Labelling System (Amersham) according to manufacturer protocol. Hybridization signals were imaged and analyzed using a Typhoon phosphorimager (GE Life Sciences). Signal intensities were measured using ImageJ. Methylation changes at Sat1 was quantified as a ratio of the intensity of the unmethylated/methylated blot regions as indicated in the respective blot.

HypCH4IV was selected for Sat1 methylation analysis over the more traditional MspI/HpaII isoschizomer pair because Sat1 sequences lack the CCGG sites that are recognized by these enzymes.

Chromatin immunoprecipitation (ChIP) {#s4-8}
------------------------------------

ChIP was performed as described in Lindeman et al. 2009 with modifications. Briefly, zebrafish juveniles at 1 month were euthanized using tricaine. Chromatin was prepared from euthanized fish by lysing flash frozen samples using an automated pulverizer (Covaris) and crosslinking using 1% Formaldehyde for 5 mins. Chromatin shearing was performed using a Covaris S220 sonicator using the following conditions: 1 ml tubes with total chromatin from each fish in buffer containing 1% SDS were sonicated using peak intensity power of 140, duty factor of 5.0 and 200 cycles per burst, for 14 min for *zbtb24^+/+^* and 6 min for *zbtb24^Δ/Δ^*. Shearing was monitored using 1% agarose gel. To provide standardized input for each ChIP experiment, chromatin was diluted to A260 = 0.2. For each ChIP, 2 μg antibody per 10 μl Dynabeads and 100 μl chromatin was incubated overnight at 4°C. Following antibodies were used in this study: anti-H3K9me3 antibody (abcam ab8898), anti-H3K27me3 (Millipore 07--449), anti-H3 (abcam 1791) and IgG control (abcam ab15008). After elution, ChIP DNA and input controls were purified using QIAquick PCR purification kit (Qiagen). Eluted DNA was analyzed by qPCR using primers targeting Sat1 ([Supplementary file 2](#supp2){ref-type="supplementary-material"}).

Enhanced Reduced Representation Bisulfite Sequencing (ERRBS) {#s4-9}
------------------------------------------------------------

50 ng of high quality genomic DNA was prepared from fin tissue from 6-month-old adult zebrafish DNA was digested with MspI and bisulfite converted using the EZ DNA methylation kit (zymo) as in [@bib22]. Bisulphite conversion rates (calculated using non-CpG methylation conversion rates) ranged from 99.6% to 99.7% for all samples ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). Amplified libraries were sequenced on the Hiseq2500 platform using a minimum of single-read 51 cycles. ERRBS data were filtered for sequence adapters, limited to the first 29 bp of the read ([@bib6]), and mapped to the zebrafish genome (danRer7) using BSmap (v 2.90) ([@bib64]). Other than limiting to the first 29 bp all other BSmap parameters were the defaults. Methylation scores were calculated as the number of unconverted reads divided by the number of total reads at each CpG site. DMRs were called as described in [@bib40]. DMRs with at least a 0.2 change in methylation were determined using DSS (delta = 0.2, p.threshold = 0.01). CallDMR function in DSS was used with default parameters except for p.threshold and delta as specified. Sat1 sequences are deficient in MspI sites, and are therefore not included in ERRBS data.

RNA expression analysis {#s4-10}
-----------------------

For qRT-PCR, total RNA was isolated using Trizol (Invitrogen) and precipitated with isopropanol. RNA used for assaying expression of repeat sequences subsequently was treated with DNase using TURBO DNA-*free* Kit (Ambion) prior to analyses. RNA was converted to cDNA using GoScript Reverse Transcriptase Kit (Promega) and Real Time PCR was performed using an Applied Biosystems 7500 PCR Machine. Analysis was performed using the 2^--ΔΔCt^ method, with relative mRNA levels of all transcripts normalized to β-actin1 or 18S. All primer sequences are listed in [Supplementary file 2](#supp2){ref-type="supplementary-material"}.

For Northern blot analysis, total RNA was extracted with using Trizol (Invitrogen). 2 μg of RNA was subjected to electrophoresis on 1% agarose gel and transferred to Amersham Hybond-N+ membrane (GE Healthcare). The membrane was probed with ^32^P-dCTP radiolabeled Sat1 DNA probe at 42**°**C. Hybridization signals were imaged and analyzed using a Typhoon phosphorimager (GE Life Sciences).

TAG-aided sense/antisense transcript detection (TASA-TD) strand-specific PCR was performed as described by ([@bib27]). Oligos used are listed in [Supplemental file 3](#supp3){ref-type="supplementary-material"}.

Transcriptome sequencing {#s4-11}
------------------------

After RiboGreen quantification and quality control by Agilent BioAnalyzer, 500 ng of total RNA underwent polyA selection and TruSeq library preparation according to instructions provided by Illumina (TruSeq Stranded mRNA LT Kit), with 8 cycles of PCR. Samples were barcoded and run on a HiSeq 2500 High Output in a 50 bp/50 bp paired end run, using the TruSeq SBS v4 Kit (Illumina). An average of 45.3 million paired reads was generated per sample. The percent of mRNA bases averaged 62.8%.

For single-mutant RNA-seq analysis presented in [Figure 3](#fig3){ref-type="fig"}, reads were mapped to the Zebrafish genome (danRer7) using the rnaStar aligner v2.5.0a ([@bib14]). We used the two-pass mapping method outlined in [@bib18]. The first mapping pass used a list of known annotated junctions from Ensemble. Novel junctions found in the first pass were then added to the known junctions and a second mapping pass was done (on the second pass the RemoveNoncanoncial flag was used). Expression counts (counts per million, cpm) were computed from the mapped reads using HTSeq v0.5.3 ([@bib2]) and Ensemble D.rerio v79 gene annotations. Normalization and differential expression was performed using DESeq ([@bib1]).

For RNA-seq analysis presented in [Figure 6](#fig6){ref-type="fig"}, raw RNA-seq FASTQ reads were trimmed for adapters and preprocessed to remove low-quality reads using Trimmomatic v0.33 (arguments: LEADING:3 TRAILING:3 MINLEN:36) ([@bib5]) prior to mapping to the *Danio rerio* GRCz10 reference genome assembly. Reads were mapped using TopHat v2.1.1 ([@bib30]) supplied with a reference General Features File (GFF) to the *Danio rerio*GRCz10 reference genome assembly, and with the following arguments: -i 10 -I 5000 \--library-type fr-firststrand. Gene expression was estimated using Cuffquant (a tool from Cufflinks v2.2.1), with following arguments \--library-type fr-firststrand. Expression level were normalized in FPKM units by Cuffnorm (a tool from Cufflinks v2.2.1), with following arguments \--library-type fr-firststrand.

5-aza-dC treatment {#s4-12}
------------------

Zebrafish embryos were treated with 5-aza-dC (Sigma-Aldrich) to the final concentration of 25 uM or 50 uM within the first 2 hr post fertilization, when zebrafish are sensitive to 5-aza-dC treatments as described in [@bib36]. At 24hpf, total RNA was collected for expression analysis. At 24hpf, genomic DNA was also collected and digested with methylation sensitive enzyme, HpaII, to test for global DNA hypomethylation.

RNA synthesis and injections {#s4-13}
----------------------------

Sat1 RNA and control RNAs were in vitro transcribed using Riboprobe in vitro transcription systems (Promega). Oligos to amplify the DNA template for in vitro transcription are included in [Supplementary file 3](#supp3){ref-type="supplementary-material"}. Sense and anti-sense transcripts were transcribed in vitro using the T3 and T7 RNA polymerases respectively. RNA was purified illustra MicroSpin G-50 Columns (GE Healthcare) and 50 ng of sense and antisense RNA was co-injected into zebrafish embryos at the 1 cell stage.

Statistical analysis {#s4-14}
--------------------

The Student unpaired 2-tailed t-test was used for statistical analysis unless specified otherwise. Statistical analysis was performed using GraphPad PRISM software.

Accession number {#s4-15}
----------------

All ERRBS and RNA-Seq data reported in this paper have been deposited in GEO under the accession GSE116360.
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In the interests of transparency, eLife includes the editorial decision letter, peer reviews, and accompanying author responses.

\[**Editorial note:** This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor\'s assessment is that all the issues have been addressed.\]

Thank you for submitting your article \"Pericentromeric hypomethylation elicits an interferon response in an animal model of ICF syndrome\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Deborah Bourchis as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Jessica Tyler as the Senior Editor. The following individuals involved in review of your submission have also agreed to reveal their identity: Ozren Bogdanovic (Reviewer \#2); Albert Jordan (Reviewer \#3).

The Reviewing Editor has highlighted the concerns that require revision and/or responses, and we have included the separate reviews below for your consideration. If you have any questions, please do not hesitate to contact us.

Below, you will find a list of the comments from the reviewers that have not been modified because we believe that you will find it useful to consider all the points. As you will see, the three reviewers are overall positive and recognize the originality and experimental quality of the work.

Please address the comments and revise your text accordingly. Limited additional experimentation is required. Defining the separate effect of sense and antisense sat1 RNAs on the interferon response was raised by two reviewers and should be included along with ds RNA injection. We also recommend to provide more insights into the fertility and germline DNA methylation phenotypes of the *Zbtb24* KO animals.

Separate reviews (please respond to each point):

*Reviewer \#1:*

The ICF syndrome is an autosomal recessive disease associated with a constitutive DNA methylation defect at pericentromeric satellite DNA. Patients present with severe immunodeficiency and facial anomalies. Although being very rare (around 100 patients worldwide), the underlying genetic causes are variable: at least four genes have been implicated -- a DNA methyltransferase (DNMT3B), a zinc-finger containing factor (ZBTB24), an helicase (HELLS) and a cell cycle regulator (CDCA7). Studying this disease has a double interest: dissecting the DNA methylation pathway, and addressing the impact of defective pericentrometic heterochromatin regulation on development and immunity functions.

The authors report here the first zebrafish model of ICF, through the constitutive loss of function of *Zbtb24*. First, this model recapitulates the typical pericentromeric hypomethylation, immunological defects and facial anomalies of ICF syndrome. Second, the authors report a new molecular component of the *Zbtb24*-related immunological phenotype: hypomethylation of the pericentrometic heterochromatin results in the production of immunostimulatory sat1 repeat transcripts, which trigger an interferon response through a viral RNA recognition pathway. This provides the novel concept that the earliest consequence of pericentromeric loss is an induction of the innate immune system. These are very interesting findings, even if we cannot conclude as to whether tis response is involved in the ICF pathology.

The manuscript is clear and concise, and the conclusions well supported by the data. The genetic approaches in particular are very solid.

I have a few requests for the authors though, to improve the clarity and breadth of the findings.

1\) It has been shown in mammals that *Zbtb24* controls the expression of *Cdca7*, whose mutations are also involved in the ICF syndrome. Is it also the case in zebrafish? Could the authors look in their RNA seq data from *Zbtb24* KO the expression pattern of this gene and comment on the result?

2\) Very recently, a ZBTB24 DNA binding motif was identified in human cells (Thompson et al., 2018). Provided that this motif is the same in zebrafish, is it present in sat1 repeats ? And in *Cdca7*, if it happens to be also a *Zbtb24* target in fishes?

3\) DNA methylation analyses by ERRBS: using this technique, the authors conclude that *Zbtb24* mostly targets pericentromeric repeats in the zebrafish genome. However, this method provides a very low coverage for regions that are not CpG-rich. ICF type 2 patients (mutated for the ZBTB24 gene) were recently shown to have DNA methylation defects outside of pericentromeric repeats, at CpG-poor regions with heterochromatic features. The authors should acknowledge the limitation of their method in capturing this type of genomic sequences.

4\) DNA methylation analyses of sat1 repeats in *Zbtb24* KO: several somatic tissues were analyzed (brain, muscle and skin). What about germ cells? Sperm DNA methylation should be analyzed (see point 4 in this regards). Protocols have been previously published about zebrafish sperm DNA extraction.

5\) Phenotype: the authors report in the Discussion that they could not address as to whether the maternal store of *Zbtb24* could mask requirement in DNA methylation establishment because mutant zebrafishes were sterile (I guess this concerns the 10% survivors). Both females *and* males? Regarding the tight link between DNA methylation and fertility in other models, more information about this sterility phenotype is required: are mature germ cells produced (ovary and testis histological sections could give an quick answer)? Of course if males lack sperm, then the analysis requested in \#2 becomes invalid.

6\) The ability of sat1 repeat transcripts to trigger the expression of ISG genes was assessed with a mixture of sense and antisense RNAs (Figure 5F). The authors should also inject separately sense and antisense products to assess their relative effect on the interferon response and gain mechanistic insights into the origin of this response.

7\) One point I find missing from the Discussion: what do we know about the dynamics of DNA methylation during early zebrafish development? Is there something specific going on at two weeks, when *Zbtb24* function becomes essential? See data from the labs of B. Cairns and R. Lister.

Minor Comments:

\- Msp1 should be spelled MspI.

\- Age at which the ERRBS was performed: the text says at 25 wpf (*Zbtb24* mutants exhibit modest reductions in 5mC at non-pericentromeric sequences), Materials and methods reports 24 wpf.

\- DMR call: information is missing about the criteria: size? Sliding window?

*Reviewer \#2:*

Vertebrate genomes display high levels of DNA methylation covering repetitive elements, inactive cis-regulatory sequences, intergenic regions, and gene bodies. Numerous functional studies have demonstrated the importance of proper DNA methylation patterning for diverse developmental processes. Nevertheless, such studies frequently suffer from the inability to determine which loci in particular were causal for the phenotypes observed upon the loss of activity of proteins that deposit, read, and write DNA methylation patterns.

The study by Rajshekar et al. provides an exciting system for exploring how loss of DNA methylation from pericentromeric satellite repeats affects vertebrate development. Here the authors mutated the zebrafish *zbtb24* gene, which was previously implicated in Immunodeficiency, Centromere and Facial abnormalities (ICF) syndrome in humans. Importantly, mammalian models for this disorder are either embryonically lethal, or they exhibit immediate post-natal lethality. Using a combination of elegant functional and genome-wide approaches the authors demonstrate how pericentromeric hypomethylation elicits an interferon response in the affected animals. Overall, the presented work is well executed and the manuscript is clearly and concisely written. Significant efforts have been placed in the preparation of the figures, which will make the results easy to understand even for a non-specialist reader. My suggestions for improvement are relatively minor:

1\) It would be useful to discuss in more detail what the proposed function of ZBTB24 is. Is it a DNA methylation reader, a chromatin remodeller (I note that it has a helicase domain)? Also, a couple of sentences describing the potential reasons for differences in the observed zebrafish and mouse phenotypes upon the loss of ZBTB24, would be welcome.

2\) The ERRBS data are of high interest and will likely be reused in similar studies. I would urge the authors to include more details as to how these libraries were generated and mapped (i.e. how many PCR cycles, which BS-conversion kit, and mapping/mC calling parameters).

3\) The scatter plot in Figure 2E leaves the impression as if the majority of CpGs are reduced in the mutant for some 10-20%. This is, of course, difficult to determine by just looking at the scatterplot and even more so if no legend depicting the range of densities is included in the figure. I feel that RRBS data would require some further analysis to unequivocally demonstrate the proposed small magnitude of the changes between the wt and the mutant. I would suggest representing the distributions of 5mC levels at single CpGs in wt and mutant triplicates with boxplots, and stacked bar plots (i.e.% of CpGs with low: 0-0.2, medium: 0.2-0.8, and high: \> 0.8 5mC levels). These, and perhaps other analysis, will be better suited for demonstrating the magnitude of changes in 5mC between the wt and the mutant. Also, could the authors comment on the proposed mechanism for this apparent genome-wide 5mC loss in the mutant?

4\) Is this global 5mC loss correlated with any genomic feature in particular?

5\) I would remove the non-significant P values from Figures 3, 4 and 5 and just state \"n.s\" instead. This will allow the reader to immediately focus on the significant changes. I would consider replacing all the P values with \*, \*\*, or \*\*\* -- denoting increasing significance levels, and just state the P value ranges in figure legends.

Overall, this is a strong paper on a topic of high interest that sets the stage for exciting future studies. For example, it will be interesting to see how specific the *mda5* response is and what other types of RNA can activate these pathways.

*Reviewer \#3:*

The manuscript describes a model of ICF syndrome in zebrafish by mutating the ZBTB24 gene, previously described as an ICF-gene. This model recapitulates an ICF hallmark that is pericentromeric (SAT1) hypomethylation. Authors describe that hypomethylation does not affect other genomic regions. As a consequence SAT1 transcripts are detected, parallel to expression of ISGs (IFN response) that may be related to autoimmunity. They show that the IFN pathway dsRNA sensor MDA5-MAVS is required for those effects, sensing SAT1 transcripts.

It is not clear how ZBTB24 mutant can generate specific demethylation of pericentromeric repeats only, nor what is the relation between ISG upregulation and ICF etiology. Nonetheless, experiments are consistent and proof well the relation between hypomethylation, SAT1 expression and IFN pathway activation through the dsRNA sensors. Similar experiments have been performed elsewhere with DNA methylation inhibitor drugs in human cancer cells (or by histone H1 depletion).

Major comments:

1\) It would be nice to test whether aza-dC causes the same effects as ZBTB24 mutation in zebrafish.

2\) In the experiment of SAT1 dsRNA injection, it might be done in parallel with sense and antisense RNA separately to proof dsRNA is required.

3\) It would have been nice to analyze by ChIP what changes occur in SAT1 upon ZBTB24 mutation apart from hypomethylation, for example in terms of repressive histone marks.

Minor comments:

Figure 6A and C might be A and B (3 and 6 weeks, respectively). RNAseq on C.
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Author response

Reviewer \#1:

> \[...\] The manuscript is clear and concise, and the conclusions well supported by the data. The genetic approaches in particular are very solid.
>
> I have a few requests for the authors though, to improve the clarity and breadth of the findings.
>
> 1\) It has been shown in mammals that Zbtb24 controls the expression of Cdca7, whose mutations are also involved in the ICF syndrome. Is it also the case in zebrafish? Could the authors look in their RNA seq data from Zbtb24 KO the expression pattern of this gene and comment on the result?

Our RNA-seq data does indicate that *cdca7* expression is downregulated in *zbtb24^Δ/Δ^* mutant zebrafish and we have confirmed this result by qRT-PCR. The relevant data is now included in Figure 6---figure supplement 1 and we include a discussion of this point in the fifth paragraph of the Discussion.

> 2\) Very recently, a ZBTB24 DNA binding motif was identified in human cells (Thompson et al., 2018). Provided that this motif is the same in zebrafish, is it present in sat1 repeats ? And in Cdca7, if it happens to be also a Zbtb24 target in fishes?

Thompson et al., 2018, identified a *ZBTB24* DNA binding motif: AGGTCCTGGCAG, in human cells. We used Find Individual Motif Occurrences (FIMO) (Grant et al., 2011), to search for occurrence of this motif in the zebrafish genome. We did not find this motif in the promoter or gene body of *cdca7* or in Sat1 repeats. We now include this point in our Discussion (fifth paragraph).

> 3\) DNA methylation analyses by ERRBS: using this technique, the authors conclude that Zbtb24 mostly targets pericentromeric repeats in the zebrafish genome. However, this method provides a very low coverage for regions that are not CpG-rich. ICF type 2 patients (mutated for the ZBTB24 gene) were recently shown to have DNA methylation defects outside of pericentromeric repeats, at CpG-poor regions with heterochromatic features. The authors should acknowledge the limitation of their method in capturing this type of genomic sequences.

We now highlight this limitation in our Discussion (third paragraph).

> 4\) DNA methylation analyses of sat1 repeats in Zbtb24 KO: several somatic tissues were analyzed (brain, muscle and skin). What about germ cells? Sperm DNA methylation should be analyzed (see point 4 in this regards). Protocols have been previously published about zebrafish sperm DNA extraction.

We agree that analysis of germ cells is of interest, and we have performed these experiments. However, we were somewhat hesitant to include this data in the original manuscript as the results are unexpected and raise questions that we feel are outside the scope of the current manuscript. While far less sperm is recovered from *zbtb24* mutants compared to wildtype, some sperm can be recovered. Unexpectedly, we find that methylation levels in the recovered sperm from *zbtb24^Δ/Δ^* males are comparable to wildtype. This is in contrast to all somatic tissues we have examined. We now include this finding in Figure 2---figure supplement 1C-D. A description of the result is presented in the first paragraph of the subsection "Progressive methylation loss at pericentromeric repeats in *zbtb24* mutants"and some discussion is included in the second paragraph of the Discussion, our methods for sperm recovery are provided in the subsection "Sperm Count".

> 5\) Phenotype: the authors report in the Discussion that they could not address as to whether the maternal store of Zbtb24 could mask requirement in DNA methylation establishment because mutant zebrafishes were sterile (I guess this concerns the 10% survivors). Both females and males? Regarding the tight link between DNA methylation and fertility in other models, more information about this sterility phenotype is required: are mature germ cells produced (ovary and testis histological sections could give an quick answer)? Of course if males lack sperm, then the analysis requested in \#2 becomes invalid.

As discussed in response to comment 4 above, the sterility in phenotype *zbtb24^Δ/Δ^* mutants appears complicated, and substantial investigation beyond the scope of this manuscript may be needed to fully understand it. All attempts to cross male and female mutant fish with each other or to outcross male or female mutants to wildtype have been unsuccessful. We do find that the testes in *zbtb24^Δ/Δ^* mutants are thinner compared to wildtype siblings and that the sperm count in *zbtb24^Δ/Δ^* mutants is significantly reduced when we dissect and manually grind up whole testes to extract sperm. However, histological sections reveal overtly normal male and female gonads with formation of what appear to be mature sperm and eggs. For reasons that are unclear to us, we have been unable to recover these seemingly mature germ cells using traditional methods for in vitro fertilization (which we routinely employ in the lab). We now provide this characterization as *zbtb24*supplementary material (Figure 1---figure supplement 3) and describe these findings in the subsection "Mutation of zebrafish causes ICF syndrome-like phenotypes". Methods for histology and sperm counting are included in the subsections "Histology" and "Sperm count" respectively.

> 6\) The ability of sat1 repeat transcripts to trigger the expression of ISG genes was assessed with a mixture of sense and antisense RNAs (Figure 5F). The authors should also inject separately sense and antisense products to assess their relative effect on the interferon response and gain mechanistic insights into the origin of this response.

We have now included additional experimental data for sense and antisense transcripts injected individually. In contrast to combined injection of sense and antisense RNA which reproducibly yielded significant upregulation of ISGs, we find lower level and more variable induction of only some ISGs when either sense or antisense RNA is injected alone. We include this data in Figure 5---figure supplement 2 and we include potential interpretations of this result in the (subsection **"**Pericentromeric RNA transcripts are sufficient to trigger the interferon response in *zbtb24* mutants", last paragraph and Discussion, seventh paragraph).

> 7\) One point I find missing from the Discussion: what do we know about the dynamics of DNA methylation during early zebrafish development? Is there something specific going on at two weeks, when Zbtb24 function becomes essential? See data from the labs of B. Cairns and R. Lister.

Dynamics of DNA methylation across early zebrafish development have been extensively characterized (Jiang et al., 2013; Potok et al., 2013, Bogdanovic, 2016). But these analyses have focused on developmental stages prior to 48 hpf. To the best of our knowledge genome-wide methylome analyses on zebrafish has not been performed at 2 weeks post fertilization or in the window surrounding this time point. As such, we are unaware of any developmental or methylation milestones that can account for the onset of hypomethylation in *zbtb24* mutants. Rather, we speculate that the onset of methylation loss at this stage partly reflects the need to deplete maternally loaded *zbtb24* prior to unmasking of the *zbtb24* mutant phenotype and partly reflects the culmination of minor methylation losses due to lower fidelity maintenance over many rounds of cell division. We now include text to this effect in the fourth paragraph of the Discussion.

> Minor Comments:
>
> \- Msp1 should be spelled MspI.

Msp1 has been changed to MspI in the manuscript.

> \- Age at which the ERRBS was performed: the text says at 25 wpf (Zbtb24 mutants exhibit modest reductions in 5mC at non-pericentromeric sequences), Materials and methods reports 24 wpf.

We apologize for this oversight on our part. We have revised all references to ERRBS data to indicate that animals were 6 months old.

> \- DMR call: information is missing about the criteria: size? Sliding window?

Additional details of DMR calling, as well as a reference which includes extensive details of our approach are now included in the subsection "Enhanced Reduced Representation Bisulfite Sequencing (ERRBS)".

Reviewer \#2:

> \[...\] Overall, the presented work is well executed and the manuscript is clearly and concisely written. Significant efforts have been placed in the preparation of the figures, which will make the results easy to understand even for a non-specialist reader. My suggestions for improvement are relatively minor:
>
> 1\) It would be useful to discuss in more detail what the proposed function of ZBTB24 is. Is it a DNA methylation reader, a chromatin remodeller (I note that it has a helicase domain)? Also, a couple of sentences describing the potential reasons for differences in the observed zebrafish and mouse phenotypes upon the loss of ZBTB24, would be welcome.

We now discuss the possible roles of ZBTB24 in regulating DNA methylation in the fifth paragraph of the Discussion.We really don't understand why mouse and zebrafish *zbtb24* mutant phenotypes are so different and prefer not to speculate.

> 2\) The ERRBS data are of high interest and will likely be reused in similar studies. I would urge the authors to include more details as to how these libraries were generated and mapped (i.e. how many PCR cycles, which BS-conversion kit, and mapping/mC calling parameters).

We apologize for the omission and now include the additional information on the methods including PCR cycles, BS- conversion kit and mapping/mC calling parameters in the subsection "Enhanced Reduced Representation Bisulfite Sequencing (ERRBS)".

> 3\) The scatter plot in Figure 2E leaves the impression as if the majority of CpGs are reduced in the mutant for some 10-20%. This is, of course, difficult to determine by just looking at the scatterplot and even more so if no legend depicting the range of densities is included in the figure. I feel that RRBS data would require some further analysis to unequivocally demonstrate the proposed small magnitude of the changes between the wt and the mutant. I would suggest representing the distributions of 5mC levels at single CpGs in wt and mutant triplicates with boxplots, and stacked bar plots (i.e.% of CpGs with low: 0-0.2, medium: 0.2-0.8, and high: \> 0.8 5mC levels). These, and perhaps other analysis, will be better suited for demonstrating the magnitude of changes in 5mC between the wt and the mutant. Also, could the authors comment on the proposed mechanism for this apparent genome-wide 5mC loss in the mutant?

We now also present% methylation as violin plots for individual *zbtb24* WT and mutant samples (Figure 3F). In the third paragraph of the Discussion, we now include text suggesting that low level methylation changes outside of the pericentromeres may reflect more modest requirements for *zbtb24* in maintaining methylation at these sequences.

> 4\) Is this global 5mC loss correlated with any genomic feature in particular?

We now include violin plots comparing methylation for different classes of genomic features including CpG islands, promoters and exons in Figure 2---figure supplement 4 and discuss this data in the subsection "*Zbtb24* mutants exhibit modest reductions in 5mC at non-pericentromeric sequences".

> 5\) I would remove the non-significant P values from Figures 3, 4 and 5 and just state \"n.s\" instead. This will allow the reader to immediately focus on the significant changes. I would consider replacing all the P values with \*, \*\*, or \*\*\* -- denoting increasing significance levels, and just state the P value ranges in figure legends.

We feel that providing exact p values promotes the most transparency.

> Overall, this is a strong paper on a topic of high interest that sets the stage for exciting future studies. For example, it will be interesting to see how specific the mda5 response is and what other types of RNA can activate these pathways.

Reviewer \#3:

> \[...\] It is not clear how ZBTB24 mutant can generate specific demethylation of pericentromeric repeats only, nor what is the relation between ISG upregulation and ICF etiology. Nonetheless, experiments are consistent and proof well the relation between hypomethylation, SAT1 expression and IFN pathway activation through the dsRNA sensors. Similar experiments have been performed elsewhere with DNA methylation inhibitor drugs in human cancer cells (or by histone H1 depletion).
>
> Major comments:
>
> 1\) It would be nice to test whether aza-dC causes the same effects as ZBTB24 mutation in zebrafish.

As requested, we exposed zebrafish embryos to 5 azaC and observed upregulation of interferon stimulated genes. This experiment is presented in Figure 3---figure supplement 2 and discussed in the subsection "Mutation of *zbtb24* causes activation of innate immune response genes". Methods are provided inthe subsection **"**5-aza-dC Treatment". This is finding consistent with earlier reports in the literature demonstrating activation of an innate immune response in *dnmt1^-/-^* zebrafish embryos undergoing global DNA hypo methylation (Chernyavskaya et al., 2017). This paper, along with other findings linking global DNA hypomethylation to innate immunity are referenced in the first paragraph of the Introduction.

> 2\) In the experiment of SAT1 dsRNA injection, it might be done in parallel with sense and antisense RNA separately to proof dsRNA is required.

See response to reviewer 1 comment 6.

> 3\) It would have been nice to analyze by ChIP what changes occur in SAT1 upon ZBTB24 mutation apart from hypomethylation, for example in terms of repressive histone marks.

We now include ChIP-qPCR and immunofluorescence data assessing H3K9me3 and H3K27me3 in Figure 2---figure supplement 2.Methods are presented inthe subsection "Chromatin Immunoprecipitation (ChIP)" and we highlight these findings in the last paragraph of the subsection "Progressive methylation loss at pericentromeric repeats in *zbtb24* mutants". We did not observe any obvious changes in these repressive histone marks.

> Minor comments:
>
> Figure 6A and C might be A and B (3 and 6 weeks, respectively). RNAseq on C.

We have made this change.
